original ) (raw )The B cell targeted adjuvant, CTA1-DD, exhibits potent mucosal immunoenhancing activity despite pre-existing anti-toxin immunity
Nils Lycke
Vaccine, 2001
View PDFchevron_right
The combined CTA1-DD/ISCOM adjuvant vector promotes priming of mucosal and systemic immunity to incorporated antigens by specific targeting of B cells
Karin Lovgren
The Journal of …, 2006
View PDFchevron_right
Development of Safe and Non-Self-Immunogenic Mucosal Adjuvant by Recombinant Fusion of Cholera Toxin A1 Subunit with Protein Transduction Domain
Cecil Czerkinsky
Journal of immunology research, 2018
View PDFchevron_right
Chimeras of Labile Toxin One and Cholera Toxin Retain Mucosal Adjuvanticity and Direct Th Cell Subsets Via Their B Subunit
Prosper Boyaka
The Journal of Immunology, 2003
View PDFchevron_right
Immunogenic properties of trivalent recombinant protein composed of B-subunits of LT, STX-2, and CT toxins
A. Salmanian
Microbes and Infection, 2016
View PDFchevron_right
Cholera Toxin B Subunit as a Carrier Molecule Promotes Antigen Presentation and Increases CD40 and CD86 Expression on Antigen-Presenting Cells
Kristina Eriksson
Infection and Immunity, 2001
View PDFchevron_right
Cholera Toxin and Its B Subunit Promote Dendritic Cell Vaccination with Different Influences on Th1 and Th2 Development
Kristina Eriksson
Infection and Immunity, 2003
View PDFchevron_right
Transcutaneous Immunization with Cholera Toxin B Subunit Adjuvant Suppresses IgE Antibody Responses Via Selective Induction of Th1 Immune Responses
Cecil Czerkinsky
The Journal of Immunology, 2003
View PDFchevron_right
Activity of the Holotoxin Dependence on the ADP-Ribosyltransferase Mediate the Cholera Toxin Adjuvant Effect : Splenic Marginal Zone Dendritic Cells
Nils Lycke
2005
View PDFchevron_right
Recombinant Antigen-Enterotoxin A2/B Chimeric Mucosal Immunogens Differentially Enhance Antibody Responses and B7-Dependent Costimulation of CD4+ T Cells
Michael Russell
Infection and Immunity, 2001
View PDFchevron_right
Addressing the Immunogenicity of the Cargo and of the Targeting Antibodies with a Focus on Deimmunized Bacterial Toxins and on Antibody-Targeted Human Effector Proteins
Itai Benhar
Biomedicines
View PDFchevron_right
Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletion
Marla Weetall
Protein Engineering Design and Selection, 2001
View PDFchevron_right
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants
Giuseppe Giudice
Vaccine, 2001
View PDFchevron_right
A Nontoxic Chimeric Enterotoxin Adjuvant Induces Protective Immunity in Both Mucosal and Systemic Compartments with Reduced IgE Antibodies
Kohtaro Fujihashi
The Journal of Infectious Diseases, 2002
View PDFchevron_right
Coupling of antigen to cholera toxin for dendritic cell vaccination promotes the induction of MHC class I-restricted cytotoxic T cells and the rejection of a cognate antigen-expressing model tumor
Kristina Eriksson
European Journal of Immunology, 2004
View PDFchevron_right
The role of ADP-ribosylation and GM1-binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat-labile enterotoxin and Vibrio cholerae cholera toxin
Lolke de Haan
Immunology and Cell Biology, 1998
View PDFchevron_right
A Second Generation of Double Mutant Cholera Toxin Adjuvants: Enhanced Immunity without Intracellular Trafficking
Kohtaro Fujihashi
The Journal of Immunology, 2006
View PDFchevron_right
Novel Immunostimulatory Agent Based on CpG Oligodeoxynucleotide Linked to the Nontoxic B Subunit of Cholera Toxin
A. Harandi , Denise Kelly
The Journal of Immunology, 2006
View PDFchevron_right
Mucosal Adjuvant Properties of Mutant LT-IIa and LT-IIb Enterotoxins That Exhibit Altered Ganglioside-Binding Activities
Sergio Arce
Infection and Immunity, 2005
View PDFchevron_right
Mucosal Vaccine Targeting Improves Onset of Mucosal and Systemic Immunity to Botulinum Neurotoxin A
Dagmara Zlotkowska
The Journal of Immunology, 2006
View PDFchevron_right
Potent Neutralization of Staphylococcal Enterotoxin B by Synergistic Action of Chimeric Antibodies
David Margulies
Infection and Immunity, 2010
View PDFchevron_right
Evidence for a role of ganglioside GM1 in antigen presentation: binding enhances presentation of Escherichia coli enterotoxin B subunit (EtxB) to CD4+ T cells
Richard Mitchell
International Immunology, 2001
View PDFchevron_right
Mutants of Type II Heat-Labile Enterotoxin LT-IIa with Altered Ganglioside-Binding Activities and Diminished Toxicity Are Potent Mucosal Adjuvants
Sergio Arce
Infection and Immunity, 2007
View PDFchevron_right
Interference of the T Cell and Antigen-Presenting Cell Costimulatory Pathway Using CTLA4-Ig (Abatacept) Prevents Staphylococcal Enterotoxin B Pathology
Sjoerd Rijpkema
Journal of immunology (Baltimore, Md. : 1950), 2017
View PDFchevron_right
Dendritic Cell-Mediated Induction of Mucosal Cytotoxic Responses following Intravaginal Immunization with the Nontoxic B Subunit of Cholera Toxin
Cecil Czerkinsky
The Journal of Immunology, 2006
View PDFchevron_right
Mutational analysis of the role of ADP-ribosylation activity and GM1 -binding activity in the adjuvant properties of theEscherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin
Lolke de Haan
European Journal of Immunology, 1998
View PDFchevron_right
Cutting Edge: The Mucosal Adjuvant Cholera Toxin Redirects Vaccine Proteins into Olfactory Tissues
Jerry McGhee
The Journal of Immunology, 2000
View PDFchevron_right
Delivery of Antigens to the MHC Class I Pathway Using Bacterial Toxins
Kurt Klimpel
Human Immunology, 1997
View PDFchevron_right
Increasing immunogenicity of antigens fused to Ig-binding proteins by cell surface targeting
Pascal Drevet
Journal of immunology (Baltimore, Md. : 1950), 1998
View PDFchevron_right
Intranasal Immunogenicity and Adjuvanticity of Site-Directed Mutant Derivatives of Cholera Toxin
Maria Fontana
Infection and Immunity, 1997
View PDFchevron_right
Recombinant immunotoxins for treating cancer
Wyndham Wilson
International Journal of Medical Microbiology, 2004
View PDFchevron_right
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA
Cecil Czerkinsky
Expert Review of Vaccines, 2003
View PDFchevron_right